Natera has released new data from the GALAXY arm of its ongoing CIRCULATE-Japan trial showing the efficacy of its molecular ...

To combat counterfeit semiconductors, researchers at Purdue University’s College of Engineering have developed an optical ...

Adela’s tissue-agnostic MRD test has been clinically validated to predict and surveil for recurrence in patients with head & ...

Personalis, Inc. (Nasdaq: PSNL), a leader in MRD testing, announced findings presented this week at the European Society of Medical Oncology Congress (ESMO) Congress 2024 in Barcelona, Spain.

Certain genetic changes, or mutations, can increase the chances of leukemia or blood cancer. According to experts, leukemia, ...

Drs Kathy D. Miller and Heather A. Parsons explore the complexities and evolving strategies in managing HER2+ oligometastatic ...

This data provides the first evidence of Signatera-based molecular residual disease (MRD) detection to predict overall survival (OS) and highlights Signatera’s ability to predict adjuvant chemotherapy ...

Purdue University researchers have developed RAPTOR, a patent-pending optical counterfeit detection method for chips used in semiconductor devices. It leverages deep learning to identify tampering. It ...

Researchers in Purdue University's College of Engineering have developed a patent-pending optical counterfeit detection method for chips used in ...

Cancan Diagnostics is excited to announce a strategic distribution partnership with Vet Planet Ltd., a leading provider of veterinary products and s ...